Leal Matheus Tozatto Baptista Coelho, Passos Livia Silva Araújo, Guarçoni Felipe Vieira, Aguiar João Marcelo de Souza, Silva Rafael Benjamim Rosa da, Paula Thiago Mendonça Nunes de, Santos Rafael Figueiredo Dos, Nassif Maria Cecília Landim, Gomes Nayana F A, Tan Timothy C, Nunes Maria Carmo Pereira
Faculdade de Medicina da Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brasil.
The Center for Excellence in Vascular Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Rev Soc Bras Med Trop. 2019 Mar 14;52:e20180041. doi: 10.1590/0037-8682-0041-2019.
Rheumatic heart disease (RHD) remains a major cause of preventable death and disability in children and young adults. Despite significant advances in medical technology and increased understanding of disease mechanisms, RHD continues to be a serious public health problem throughout the world, especially in low- and middle-income countries. Echocardiographic screening has played a key role in improving the accuracy of diagnosing RHD and has highlighted the disease burden. Most affected patients present with severe valve disease and limited access to life-saving cardiac surgery or percutaneous valve intervention, contributing to increased mortality and other complications. Although understanding of disease pathogenesis has advanced in recent years, key questions remain to be addressed. Preventing or providing early treatment for streptococcal infections is the most important step in reducing the burden of this disease.
风湿性心脏病(RHD)仍然是儿童和年轻人可预防死亡和残疾的主要原因。尽管医疗技术取得了重大进展,对疾病机制的认识也有所提高,但RHD在全球范围内仍然是一个严重的公共卫生问题,尤其是在低收入和中等收入国家。超声心动图筛查在提高RHD诊断准确性方面发挥了关键作用,并凸显了疾病负担。大多数受影响的患者患有严重瓣膜疾病,获得挽救生命的心脏手术或经皮瓣膜介入治疗的机会有限,这导致死亡率和其他并发症增加。尽管近年来对疾病发病机制的认识有所进步,但关键问题仍有待解决。预防或早期治疗链球菌感染是减轻这种疾病负担的最重要步骤。